Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Accelerated Phase × entrectinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 3 Thyroid Cancer, Papillary 2 Sarcoma 2 Salivary Gland Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Glioma 2 Central Nervous System Neoplasms 2 Wilms Tumor 1 Solid Tumors 1 Sarcoma, Ewing 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephroma, Mesoblastic 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Melanoma 1 Medulloblastoma 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1

Interventions

Cyclophosphamide 8 fludarabine phosphate 5 Methotrexate 5 ponatinib 4 Whole-Body Irradiation 4 merphos 3 Tacrolimus 3 Rituximab 3 Peripheral Blood Stem Cell Transplantation 3 Mycophenolic Acid 3 CT-P10 3 Busulfan 3 letermovir 2 Vincristine 2 Melphalan 2 Cytarabine 2 Cyclosporine 2 venetoclax 1 prednylidene 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 bosutinib 1 blinatumomab 1 auricularum 1 Vorinostat 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡